Home >> Research Area >>Neuroscience>>Dopamine Receptor>>Alkaloids>> Dopamine hydrochloride

Dopamine hydrochloride

Endogenous agonist at dopamine D1-5 receptors CAS# 62-31-7

Dopamine hydrochloride

Catalog No. BCN2195----Order now to get a substantial discount!

Product Name & Size Price Stock
Dopamine hydrochloride:100mg $69.00 In stock
Dopamine hydrochloride:200mg $117.00 In stock
Dopamine hydrochloride:500mg $276.00 In stock
Dopamine hydrochloride:1000mg $483.00 In stock
Related Products
  • Repaglinide

    Catalog No.:BCC2504
    CAS No.:135062-02-1
  • Dronedarone

    Catalog No.:BCN2176
    CAS No.:141626-36-0
  • NS309

    Catalog No.:BCC1809
    CAS No.:18711-16-5
  • TRAM-34

    Catalog No.:BCC1122
    CAS No.:289905-88-0

Quality Control of Dopamine hydrochloride

Number of papers citing our products

Chemical structure

Dopamine hydrochloride

3D structure

Chemical Properties of Dopamine hydrochloride

Cas No. 62-31-7 SDF Download SDF
PubChem ID 65340 Appearance White powder
Formula C8H11NO2 M.Wt 153.18
Type of Compound Alkaloids Storage Desiccate at -20°C
Synonyms ASL279
Solubility Soluble to 100 mM in water and to 100 mM in DMSO
Chemical Name 4-(2-aminoethyl)benzene-1,2-diol;hydrochloride
SMILES C1=CC(=C(C=C1CCN)O)O.Cl
Standard InChIKey CTENFNNZBMHDDG-UHFFFAOYSA-N
Standard InChI InChI=1S/C8H11NO2.ClH/c9-4-3-6-1-2-7(10)8(11)5-6;/h1-2,5,10-11H,3-4,9H2;1H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of Dopamine hydrochloride

DescriptionDopamine hydrochloride is a catecholamine neurotransmitter present in a wide variety of animals,And a dopamine D1-5 receptors agonist.
TargetsDopamine Receptor
In vivo

Cardiovascular effects of dopamine hydrochloride and phenylephrine hydrochloride in healthy isoflurane-anesthetized New Zealand White rabbits (Oryctolagus cuniculus).[Pubmed: 25629908]

Am J Vet Res. 2015 Feb;76(2):116-21.

To determine the cardiopulmonary effects of progressively increasing infusion rates of Dopamine hydrochloride and phenylephrine hydrochloride in healthy adult New Zealand White rabbits anesthetized with isoflurane. ANIMALS: 6 New Zealand White rabbits. (Oryctolagus cuniculus).
METHODS AND RESULTS:
Each rabbit was anesthetized on 2 occasions (≥ 2 weeks apart) with isoflurane in oxygen at 1.5 times the published isoflurane minimum alveolar concentration of 2.07%. Carotid artery and pulmonary artery catheters were placed. During each anesthetic episode, each rabbit received 5 progressively increasing doses of either dopamine (5, 10, 15, 20, or 30 μg/kg/min) or phenylephrine (0.125, 0.25, 0.5, 1.0, and 2.0 μg/kg/min). Blood gas and cardiopulmonary measurements were obtained after a 20-minute equilibration period prior to administration of the first drug dose (baseline) and after each subsequent dose administration. Dopamine increased stroke index at the highest infusion rate of 30 μg/kg/min; however, cardiac output and mean arterial blood pressure remained unchanged from baseline values. Administration of phenylephrine at a rate of 2 μg/kg/min increased mean arterial blood pressure to 62 mm Hg from the baseline value of 45 mm Hg. This was a result of an increase in systemic vascular resistance with a concomitant decrease in heart rate and no change in cardiac output. Blood lactate concentration increased with time when rabbits received either treatment.
CONCLUSIONS:
Within the dose range of 5 to 30 μg/kg/min, dopamine was not an effective treatment for isoflurane-induced hypotension in rabbits and phenylephrine was only minimally effective at a dose of 2 μg/kg/min.

Protocol of Dopamine hydrochloride

Structure Identification
J Chem Phys. 2015 Jan 7;142(1):014502.

Conformation and interactions of dopamine hydrochloride in solution.[Pubmed: 25573567]


METHODS AND RESULTS:
The aqueous solution of Dopamine hydrochloride has been investigated using neutron and X-ray total scattering data together with Monte-Carlo based modelling using Empirical Potential Structure Refinement. The conformation of the protonated dopamine molecule is presented and the results compared to the conformations found in crystal structures, dopamine-complexed protein crystal structures and predicted from theoretical calculations and pharmacophoric models. It is found that protonated dopamine adopts a range of conformations in solution, highlighting the low rotational energy barrier between different conformations, with the preferred conformation being trans-perpendicular.
CONCLUSIONS:
The interactions between each of the species present (protonated dopamine molecules, water molecules, and chloride anions) have been determined and are discussed with reference to interactions observed in similar systems both in the liquid and crystalline state, and predicted from theoretical calculations. The expected strong hydrogen bonds between the strong hydrogen bond donors and acceptors are observed, together with evidence of weaker CH hydrogen bonds and π interactions also playing a significant role in determining the arrangement of adjacent molecules.

Dopamine hydrochloride Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Dopamine hydrochloride Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Dopamine hydrochloride

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 6.5283 mL 32.6413 mL 65.2827 mL 130.5653 mL 163.2067 mL
5 mM 1.3057 mL 6.5283 mL 13.0565 mL 26.1131 mL 32.6413 mL
10 mM 0.6528 mL 3.2641 mL 6.5283 mL 13.0565 mL 16.3207 mL
50 mM 0.1306 mL 0.6528 mL 1.3057 mL 2.6113 mL 3.2641 mL
100 mM 0.0653 mL 0.3264 mL 0.6528 mL 1.3057 mL 1.6321 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Dopamine hydrochloride

Dopamine HCl is a catecholamine neurotransmitter present in a wide variety of animals,And a dopamine D1-5 receptors agonist.

Featured Products
New Products
 

References on Dopamine hydrochloride

Cardiovascular effects of dopamine hydrochloride and phenylephrine hydrochloride in healthy isoflurane-anesthetized New Zealand White rabbits (Oryctolagus cuniculus).[Pubmed:25629908]

Am J Vet Res. 2015 Feb;76(2):116-21.

OBJECTIVE: To determine the cardiopulmonary effects of progressively increasing infusion rates of Dopamine hydrochloride and phenylephrine hydrochloride in healthy adult New Zealand White rabbits anesthetized with isoflurane. ANIMALS: 6 New Zealand White rabbits. (Oryctolagus cuniculus). PROCEDURES: Each rabbit was anesthetized on 2 occasions (>/= 2 weeks apart) with isoflurane in oxygen at 1.5 times the published isoflurane minimum alveolar concentration of 2.07%. Carotid artery and pulmonary artery catheters were placed. During each anesthetic episode, each rabbit received 5 progressively increasing doses of either dopamine (5, 10, 15, 20, or 30 mug/kg/min) or phenylephrine (0.125, 0.25, 0.5, 1.0, and 2.0 mug/kg/min). Blood gas and cardiopulmonary measurements were obtained after a 20-minute equilibration period prior to administration of the first drug dose (baseline) and after each subsequent dose administration. RESULTS: Dopamine increased stroke index at the highest infusion rate of 30 mug/kg/min; however, cardiac output and mean arterial blood pressure remained unchanged from baseline values. Administration of phenylephrine at a rate of 2 mug/kg/min increased mean arterial blood pressure to 62 mm Hg from the baseline value of 45 mm Hg. This was a result of an increase in systemic vascular resistance with a concomitant decrease in heart rate and no change in cardiac output. Blood lactate concentration increased with time when rabbits received either treatment. CONCLUSIONS AND CLINICAL RELEVANCE: Within the dose range of 5 to 30 mug/kg/min, dopamine was not an effective treatment for isoflurane-induced hypotension in rabbits and phenylephrine was only minimally effective at a dose of 2 mug/kg/min.

Conformation and interactions of dopamine hydrochloride in solution.[Pubmed:25573567]

J Chem Phys. 2015 Jan 7;142(1):014502.

The aqueous solution of Dopamine hydrochloride has been investigated using neutron and X-ray total scattering data together with Monte-Carlo based modelling using Empirical Potential Structure Refinement. The conformation of the protonated dopamine molecule is presented and the results compared to the conformations found in crystal structures, dopamine-complexed protein crystal structures and predicted from theoretical calculations and pharmacophoric models. It is found that protonated dopamine adopts a range of conformations in solution, highlighting the low rotational energy barrier between different conformations, with the preferred conformation being trans-perpendicular. The interactions between each of the species present (protonated dopamine molecules, water molecules, and chloride anions) have been determined and are discussed with reference to interactions observed in similar systems both in the liquid and crystalline state, and predicted from theoretical calculations. The expected strong hydrogen bonds between the strong hydrogen bond donors and acceptors are observed, together with evidence of weaker CH hydrogen bonds and pi interactions also playing a significant role in determining the arrangement of adjacent molecules.

Role of dopamine in the motivational and cognitive control of behavior.[Pubmed:18660464]

Neuroscientist. 2008 Aug;14(4):381-95.

Brain dopamine has often been implicated in impulsive and/or inflexible behaviors, which may reflect failures of motivational and/or cognitive control. However, the precise role of dopamine in such failures of behavioral control is not well understood, not least because they implicate paradoxical changes in distinct dopamine systems that innervate dissociable neural circuits. In addition, there are large individual differences in the response to dopaminergic drugs with some individuals benefiting from and others being impaired by the same drug. This complicates progress in the understanding of dopamine's role in behavioral control processes, but also provides a major problem for neuropsychiatry, where some individuals are disproportionately vulnerable to the adverse effects of dopamine-enhancing drugs on motivation and cognition. Recent progress is reviewed from cognitive and behavioral neuroscience research on motivation and cognitive control, which begins to elucidate the factors that mediate the complex roles of mesolimbic, mesocortical, and nigrostriatal dopamine in behavioral control.

Novel insights in dopamine receptor physiology.[Pubmed:17413183]

Eur J Endocrinol. 2007 Apr;156 Suppl 1:S13-21.

The dopaminergic system has a pivotal role in the central nervous system but also plays important roles in the periphery, mainly in the endocrine system. Dopamine exerts its functions via five different receptors, named D(1)-D(5), belonging to the category of G protein coupled membrane receptors. Dopamine receptors are heterogeneously expressed in different cells, tissues and organs, where they stimulate or inhibit different functions, including neurotransmission and hormone synthesis and secretion. In particular, the dopamineric system has a pivotal role in the physiological regulation of the hypothalamus-pituitary-adrenal axis. Recent data have demonstrated the expression and function of dopamine receptors not only in endocrine organs but also in endocrine tumors, mainly those belonging to the hypothalamus-pituitary-adrenal axis, and also in the so-called 'neuroendocrine' tumors. These data confirm the important role of the dopaminergic system in this endocrine axis, as well as in the neuroendocrine system. This review summarizes the main structural and functional characteristics of dopamine receptors, emphasizing the most recent novelties, and focused on the physiological and pathological regulation of the hypothalamus-pituitary-adrenal axis by the dopaminergic system. In addition, the recent findings on the relationship between dopamine receptors and neuroendocrine tumors are summarized.

Description

Dopamine HCl is a catecholamine neurotransmitter present in a wide variety of animals,And a dopamine D1-5 receptors agonist.

Keywords:

Dopamine hydrochloride,62-31-7,ASL279,Natural Products,Dopamine Receptor, buy Dopamine hydrochloride , Dopamine hydrochloride supplier , purchase Dopamine hydrochloride , Dopamine hydrochloride cost , Dopamine hydrochloride manufacturer , order Dopamine hydrochloride , high purity Dopamine hydrochloride

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: